Remove Nurses Remove Production Remove Regulations
article thumbnail

ISSUE NO. 43 — Advancing Vision Care With Formulation and Manufacture of Ocular Therapeutics

Alta Sciences

These structures resist water-based drugs, limit absorption, and tightly regulate what enters the inner eye. For conditions that require surgery or corrective devices, eye drops are an important part of diagnosis, and pre- and post-surgery treatment plans. Additionally, the eye's rapid tear film turnover continuously flushes out medication.

article thumbnail

Coronavirus: Health workers' army to be trained to deliver Covid vaccine

The Pharma Data

The Department of Health and Social Care (DHSC) said this could include training a wider range of existing NHS staff, as well as student doctors and nurses. Proposals, which are being considered in a three-week consultation , are designed to cut red tape and prevent any delays between a vaccine being found and then given to the UK population.

Vaccine 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What are value-added medicines?

Altus Drug Development

Value-added medicines are drug products and treatments created using known molecules through a process known as drug repositioning. Value-added pharmaceutical products can deliver a wide variety of improvements for patients and healthcare professionals. New combination products. Completely new formulations may also be created.

article thumbnail

What value-added medicines might bring to society

Altus Drug Development

Value-added medicines are drug products created using already known molecules. Drug reformulations are created by investigating already existing pharmaceutical products. The need for value-added medicines Value-based healthcare aims to rethink, reinvent, and optimize drug products, creating innovative treatment options.

article thumbnail

ReWalk Robotics announces the Appointment of Randel E. Richner, BSN, MPH to its Board of Directors

The Pharma Data

Richner received a Master of Public Health in Health Policy and Administration and a Bachelor of Science in Nursing from the University of Michigan in Ann Arbor, Michigan. Throughout my career, I have sought to enable access to breakthrough technologies as an important element of public health policy.

article thumbnail

Key Items Auditors Look for When Reviewing an Investigator Site File

Advarra

Verify names, address(es), and other relevant information are correct for the following: All investigator sites where the participants are seen for trial procedures and the investigational product (IP) shipment address(es) are recorded in section 3. In some countries, local regulations may indicate the sub-investigators need to sign as well.

article thumbnail

2021 AAN highlight impact and breadth of expanding neuroscience portfolio

The Pharma Data

Roche’s Chief Medical Officer and Head of Global Product Development. “We Roche will present data on the increased use of home nursing capabilities in the Phase III GRADUATE studies of gantenerumab during the COVID-19 pandemic, which enabled home-bound trial participants to continue dosing to maintain medicine exposure.